Ownership

Samuel Kintz - Insider Trading & Ownership

Entity: Individual
Location: Enliven Therapeutics Inc, 6200 Lookout Road, Boulder, CO
Summary: The estimated net worth of Samuel Kintz is at least $20.6M dollars as of March 19, 2025. Samuel Kintz is the PRESIDENT AND CEO, Director of Enliven Therapeutics, Inc. and owns shares of Enliven Therapeutics, Inc. (ELVN) stock worth about $20.6M.
All Insider Reports: All Insider Reports

Ownership of Samuel Kintz

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
ELVN, IMRA	Enliven Therapeutics, Inc.	PRESIDENT AND CEO, Director	$20.6M	-$2.93M	-12.4%	Mar 17, 2025

Insider Transactions Reported by Samuel Kintz:

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.